Lv1
40 积分 2025-09-10 加入
A Global Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Durvalumab as Sequential Therapy in Patients With Locally Advanced, Unresectable Non–Small Cell Lung Cancer Who Have Not Progressed Following Concurrent Platinum-Based Chemoradiation Therapy
27天前
已完结
HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer
3个月前
已完结
皖公网安备34019202002308
